{"brief_title": "Ondansetron for the Treatment of Cocaine Dependence - 1", "brief_summary": "The purpose of this study is to assess the efficacy and safety of ondansetron to reduce cocaine use in subjects with cocaine dependence.", "detailed_description": "Double-blind, placebo-controlled, 4-parallel group design to assess the efficacy and safety of 3 wide range doses of ondansetron to reduce cocaine use in subjects with cocaine dependence and to determine the optimal dose of ondansetron.", "condition": ["Cocaine-Related Disorders", "Drug Administration Schedule"], "intervention_type": ["Drug"], "intervention_name": ["Ondansetron"], "criteria": "Inclusion Criteria: Male/Female, at least 18 yrs of age; DSM-4 diagnosis of cocaine dependence; seeking Treatment for cocaine dependence; have ability to understand, having understood and provide written consent; females of child bearing potential that use accepted method of birth control Exclusion Criteria: Additional criteria available during screening at the site.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "99 Years", "healthy_volunteers": "No", "keyword": "cocaine dependence", "mesh_term": ["Cocaine-Related Disorders", "Ondansetron", "Cocaine"], "id": "NCT00033085"}